Cargando…
334. Impact of Overall Dexamethasone Exposure on Development of Invasive Pulmonary Aspergillosis in Hospitalized Patients with COVID-19
BACKGROUND: Abbreviated courses of corticosteroids, such as dexamethasone, have demonstrated significant improvements in clinical outcomes among patients infected with COVID-19, although chronic corticosteroid use can predispose patients to opportunistic infections. The RECOVERY trial investigators...
Autores principales: | Skoglund, Erik, Kum, Amy, Mac, Allison, Nguyen, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690695/ http://dx.doi.org/10.1093/ofid/ofab466.535 |
Ejemplares similares
-
987. Clinical Epidemiology and Outcomes of Invasive Pulmonary Aspergillosis as a Complication of Respiratory Viral Infection in Hospitalized Patients
por: De Los Santos, Bertha A, et al.
Publicado: (2021) -
Dexamethasone/tocilizumab: Invasive pulmonary aspergillosis: case report
Publicado: (2021) -
1147. Short Course of Voriconazole Therapy as a Risk Factor for Relapse of Invasive Pulmonary Aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020) -
334. Treatment Duration of Antibiotics for Sacral Osteomyelitis After Skin Flap Procedure
por: Frye, Emily, et al.
Publicado: (2020) -
324. COVID-19-Associated Pulmonary Aspergillosis (CAPA) at Veterans Affairs (VA) Hospitals in Southern California and Arizona
por: Fang, Michelle, et al.
Publicado: (2021)